[1]李俊漪,徐 剑.龙胆泻肝汤对原发性肝癌肝动脉栓塞化疗术后患者肝功能及肿瘤标志物的影响研究[J].陕西中医,2024,(10):1353-1356.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.012]
　LI Junyi,XU Jian.Longdan Xiegan decoction on liver function and tumor markers in patients with PHC after TACE[J].,2024,(10):1353-1356.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.012]
点击复制

龙胆泻肝汤对原发性肝癌肝动脉栓塞化疗术后患者肝功能及肿瘤标志物的影响研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年10期
页码:
1353-1356
栏目:
临床研究
出版日期:
2024-10-05

文章信息/Info

Title:
Longdan Xiegan decoction on liver function and tumor markers in patients with PHC after TACE
作者:
李俊漪; 徐 剑
(佳木斯大学附属第一医院普外科,黑龙江 佳木斯 154000)
Author(s):
LI Junyi; XU Jian
(General Surgery Department,the First Affiliated Hospital of Jiamusi University,Jiamusi 154000,China)
关键词:
原发性肝癌;  龙胆泻肝汤;  肝动脉栓塞化疗术;  肝功能;  肿瘤标志物;  安全性
Keywords:
Primary liver cancer;  Longdan Xiegan decoction;  Transcatheter arterial chemoembolization;  Liver function;  Tumor markers;  Security
分类号:
R 256.4
DOI:
DOI:10.3969/j.issn.1000-7369.2024.10.012
文献标志码:
A
摘要:
目的:探讨龙胆泻肝汤加减对原发性肝癌(PHC)肝动脉栓塞化疗术(TACE)后患者肝功能及肿瘤标志物的影响效果。方法:选取100例PHC TACE术后患者,按随机抽签法分为常规西医对症治疗的对照组和联合龙胆泻肝汤加减的治疗组,每组各50例,两组均治疗8周。比较两组临床疗效、中医症候积分、肝功能、肿瘤标志物水平、不良反应发生情况。结果:治疗8周后,治疗组总有效率高于对照组(P<0.05)。治疗8周后,两组恶心呕吐、肝脏肿块、胁肋疼痛、大便溏泄评分,血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、总胆红素(TB)、谷氨酰转肽酶(GTT)水平及血清癌胚抗原(CEA)、胸苷激酶1(TK1)、甲胎蛋白(AFP)、糖类抗原19-9(CA19-9)水平均低于治疗前,治疗组低于对照组(P<0.05)。治疗8周后,两组血清白蛋白(ALB)水平均高于治疗前,治疗组高于对照组(P<0.05)。治疗期间,两组不良反应比较差异无统计学意义(P>0.05)。结论:龙胆泻肝汤加减治疗可有效改善PHC TACE术后患者临床疗效、肝功能,降低肿瘤标志物水平,具有较好的治疗效果。
Abstract:
Objective:To investigate the effect of Longdan Xiegan decoction on liver function and tumor markers in patients with primary liver cancer(PHC)after transcatheter arterial chemoembolization(TACE).Methods:A total of 100 patients with PHC after TACE were randomly divided into the control group treated with conventional western medicine and the treatment group treated with Longdan Xiegan decoction,50 cases in each group.Both groups were treated for 8 weeks.The clinical efficacy,traditional Chinese medicine syndrome score,liver function,tumor marker level and adverse reactions were compared between the two groups.Results:After 8 weeks of treatment,the total effective rate of the treatment group was higher than that of the control group(P<0.05).After 8 weeks of treatment,the scores of nausea and vomiting,liver mass,hypochondriac pain,loose stool,levels of serum alanine aminotransferase(ALT),aspartate aminotransferase(AST),total bilirubin(TB),glutamyl transpeptidase(GTT)and serum carcinoembryonic antigen(CEA),thymidine kinase 1(TK1),alpha fetoprotein(AFP),carbohydrate antigen 19-9(CA19-9)levels in the two groups were lower than those before treatment,and those in the treatment group were lower than the control group(P<0.05).After 8 weeks of treatment,the level of serum albumin(ALB)in the two groups were higher than those before treatment,and the treatment group was higher than the control group(P<0.05).During the treatment,there was no significant difference in adverse reactions between the two groups(P>0.05).Conclusion:Longdan Xiegan decoction can effectively improve the clinical efficacy and liver function of patients with PHC after TACE,and reduce the level of tumor markers.It had good therapeutic effect and good safety.

参考文献/References:

[1] HUH J,KIM B,LEE J H,et al.Added value of CT arterial subtraction images in liver imaging reporting and data system treatment response categorization for transcatheter arterial chemoembolization-treated hepatocellular carcinoma[J].Invest Radiol,2021,56(2):109-116.
[2] MAKI H,HASEGAWA K.Advances in the surgical treatment of liver cancer[J].Biosci Trends,2022,16(3):178-188.
[3] 何亚莉,杨志一,强依凡,等.中药汤剂消癌化癖饮对原发性肝癌TACE术后患者血管生成因子及临床疗效的影响[J].中国医药导刊,2022,24(10):998-1003.
[4] 吴菊意,朱云.龙胆泻肝汤加减联合化疗治疗湿热内阻型原发性肝癌临床观察[J].中药材,2014,37(7):1301-1304.
[5] 中华人民共和国卫生和计划生育委员会医政医管局.原发性肝癌诊疗规范(2017年版)[J].中华肝脏病杂志,2017,25(12):886-895.
[6] 林洪生.恶性肿瘤中医诊疗指南[M].北京:人民卫生出版社,2014:372-400.
[7] 国家中医药管理局.中医病证诊断疗效标准[M].南京:南京大学出版社,1994:201-202.
[8] TSAI J H,JENG Y M,LEE C H,et al.Molecular features of primary hepatic undifferentiated carcinoma[J].Mod Pathol,2022,35(5):680-687.
[9] 付吕平,刘卫红,杨晨,等.卡瑞利珠单抗联合阿帕替尼治疗晚期肝癌的疗效与安全评价[J].河北医药,2022,44(24):3788-3790.
[10] CHANG Y,JEONG S W,YOUNG J J,et al.Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma[J].Int J Mol Sci,2020,21(21):8165.
[11] 刘贤国,徐红玉,朱江.原发性肝癌伴门静脉癌栓产生机制及经导管肝动脉化疗栓塞术联合其他介入方案治疗研究进展[J].陕西医学杂志,2023,52(10):1438-1441.
[12] 陈思攀,杨耀博,焦阳,等.经导管动脉栓塞术联合小干扰核糖核酸治疗肝癌疗效及对兔缺氧诱导因子-1、血管内皮生长因子的影响[J].陕西医学杂志,2021,50(5):534-537,549.
[13] 白雅雯,麻春杰.从《临证指南医案》探讨叶天士治肝学术经验[J].中医药通报,2022,21(6):22-24.
[14] 蒋锐沅,荣震,满婷婷,等.原发性肝癌中医证型与组织学分型及形态学分型的相关性研究[J].西部中医药,2021,34(10):99-102.
[15] 吉银,戴铭,王振常,等.逍遥散合大黄虫丸治疗原发性肝癌经肝动脉化疗栓塞术后气滞血瘀型疗效研究[J].陕西中医,2024,45(2):187-190.
[16] 周林,肖康,夏建辉.八珍汤加减辅助治疗原发性肝癌疗效及对患者外周血Th17/Treg平衡和不良反应的影响[J].陕西中医,2023,44(9):1216-1219.
[17] 李朋娟,赖丽,李红阁.加减龙胆泻肝汤对原发性肝癌TACE术后栓塞综合征患者肝功能和生活质量的影响[J].广州中医药大学学报,2021,38(5):876-879.
[18] HONG D,MIN J Y,MIN K B.Association between cadmium exposure and liver function in adults in the united states:A cross-sectional study[J].J Prev Med Public Health,2021,54(6):471-480.
[19] ZHANG J,WANG X,ZHANG L,et al.Radiomics predict postoperative survival of patients with primary liver cancer with different pathological types[J].Ann Transl Med,2020,8(13):820.
[20] GONG G Q,ZHENG K,XUE S H,et al.Serum AFU,GGT and TK1 levels in PHC patients and their correlation with clinicopathology and diagnostic value[J].Cell Mol Biol(Noisy-le-grand),2020,66(5):111-116.
[21] JIAO H B,WANG W,GUO M N,et al.Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer[J].World J Clin Cases,2022,10(26):9264-9275.
[22] 王建青.龙胆泻肝汤的渊源及临床运用概况[J].中医药通报,2020,19(1):41-43.
[23] 彭燕妮.龙胆泻肝汤治疗遗尿症肝经湿热证的临床研究[D].济南:山东中医药大学,2019.
[24] 樊燕青,孙兰池,李大鹏.茯苓酸对舌鳞状细胞癌细胞CAL-27增殖、凋亡及细胞周期的影响[J].中成药,2021,43(7):1909-1914.
[25] 田中佳,李小兰,李昊,等.甘草甜素抑癌作用及机制的研究进展[J].现代肿瘤医学,2022,30(24):4544-4548.

相似文献/References:

[1]乔喜婷,王 昊△,杨 林,等.复元活血汤合化积丸联合肝动脉栓塞化疗术治疗原发性肝癌临床研究*[J].陕西中医,2019,(8):998.
　QIAO Xiting,WANG Hao,YANG Lin,et al.Fuyuan Huoxue decoction plus Huaji pills and hepatic artery embolization in the treatment of primary liver cancer[J].,2019,(10):998.
[2]李 丹,赵 飞,王树庚.疏肝健脾散结汤联合肝动脉插管化疗栓塞术治疗原发性肝癌疗效研究[J].陕西中医,2021,(6):728.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.012]
　LI Dan,ZHAO Fei,WANG Shugeng.Effect of Shugan Jianpi Sanjie decoction combined with transcatheter arterial chemoembolization in the treatment of primary liver cancer[J].,2021,(10):728.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.012]
[3]邓台燕,王万里,杜忠群.龙胆泻肝汤坐浴联合低位全部切开高位挂线术对肛瘘患者创面愈合、肛肠动力学的影响[J].陕西中医,2021,(10):1429.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.027]
　DENG Taiyan,WANG Wanli,DU Zhongqun.Effects of Longdan Xiegan decoction for sitz bath combined with low incision and high thread-drawing on wound healing and anorectal dynamics in patients with anal fistula[J].,2021,(10):1429.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.027]
[4]赵培西,许建秦,袁 彬,等.扶正抗癌方治疗肝癌肝郁脾虚瘀毒证临床研究[J].陕西中医,2022,(12):1746.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.022]
[5]周 林,肖 康,夏建辉.八珍汤加减辅助治疗原发性肝癌疗效及对患者外周血Th17/Treg平衡和不良反应的影响[J].陕西中医,2023,(9):1216.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.013]
　ZHOU Lin,XIAO Kang,XIA Jianhui.Effect of modified Bazhen decoction adjuvant therapy on peripheral blood Th17/Treg balance and adverse reactions in patients with primary liver cancer[J].,2023,(10):1216.[doi:DOI:10.3969/j.issn.1000-7369.2023.09.013]
[6]徐巧笑,胡振斌,莫莎莎,等.从“虚、毒、瘀”浅谈原发性肝癌病机和治疗[J].陕西中医,2023,(10):1431.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.022]
　XU Qiaoxiao,HU Zhenbin,MO Shasha,et al.Discussion on pathogenesis and treatment of primary liver cancer from the perspective of “deficiency,poison,and blood stasis”[J].,2023,(10):1431.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.022]
[7]吉 银,戴 铭,王振常,等.逍遥散合大黄虫丸治疗原发性肝癌经肝动脉化疗栓塞术后气滞血瘀型疗效研究[J].陕西中医,2024,(2):187.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.008]
　JI Yin,DAI Ming,WANG Zhenchang,et al.Treatment of primary hepatocellular carcinoma qi stagnation and blood stasis type patients after TACE with Xiaoyao San combined with Dahuang Zhechong pill[J].,2024,(10):187.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.008]
[8]曹虹丽,彭廷云,陈青山,等.柴芍六君子汤对原发性肝癌患者化疗期间疗效及免疫功能的影响[J].陕西中医,2024,(11):1495.[doi:DOI:10.3969/j.issn.1000-7369.2024.11.011]
　CAO Hongli,PENG Yanyun,CHEN Qingshan,et al.Effect of Chaishao Liujunzi decoction on therapeutic effect and immune function of primary liver cancer during chemotherapy[J].,2024,(10):1495.[doi:DOI:10.3969/j.issn.1000-7369.2024.11.011]

备注/Memo

备注/Memo:
基金项目:黑龙江省教育厅基本科研项目(2018-KYYWF-0963)
更新日期/Last Update: 2024-10-08